Over 70 international experts from academia, industry and biotech will address issues to learn about the latest trends and explore hands-on approaches to tech transfer and open innovation in the field of Life Sciences, by sharing their experience and knowledge.

The last confirmed speakers are:

  • Ward Capoen, Senior Analyst, V-Bio Ventures [BE]
  • Barbara Domayne-Hayman, CBO, Puridify [UK]
  • Douglas Dundonald, Founder and Director, Anglo Scientific [UK]
  • Hakan Goker, Senior Investment Director, Merck Ventures [NL]
  • Frank Hensel, Senior Investment Manager, High-Tech Gründerfonds [DE]
  • Paul Hermant, Corporate & Finance Partner, Bird & Bird [BE]
  • Klaus Mendla, Business Development and Licensing, Boehringer Ingelheim [DE]
  • Miguel Mulet, Director Strategy and New Projects, TiGenix [BE]
  • Pascal Neuville, CEO, Domain Therapeutics [FR]
  • Michael Nowak, Owner, Nowak Ventures [US]
  • Gérard-Marie Papierok, Honorary Chairman of Eurobiomed Competitive Cluster Public Research and Clusters Partnership Manager, Virbac [FR]
  • James Peyer, Managing Partner, Apollo Ventures [US]
  • Tamar Raz, CEO, Hadasit Medical Research Services & Development [IL]
  • Christian Tidona, Director and Founder, BioMed X [DE]
  • Wendy White, Senior VP, Dohmen Life Science Services [US]